Advertisement
Additional data supports daily pre-exposure prophylaxis for HIV-negative gay men at high risk for infection. The findings were reported online Sept. 9 in The Lancet.

Supportive Evidence for Daily PrEP Curbing HIV Transmission

0
This preventive treatment should be routinely offered to gay men at high risk, researchers say
A second death has been reported in a Salmonella outbreak that has been linked to contaminated cucumbers and caused 341 illnesses in 30 states

CDC: Second Death Reported in Salmonella Outbreak

0
Tainted cucumbers also linked to 341 illnesses in 30 states, CDC officials report
Among electronic health record products

EHR Vendors Not Adhering to Usability Certification Standards

0
Several widely used EHR products found not to adhere to ONC certification requirements
An accelerated baccalaureate/doctor of medicine program does not impair the academic performance of medical students

Accelerated MD Program Doesn’t Mar Academic Performance

0
Academic performance of students is comparable in accelerated program, conventional MD program
More than half of all American adults have type 2 diabetes or prediabetes

Over Half of U.S. Adults Have Diabetes or Prediabetes

0
And many don't know they're at risk, researchers say
Multiple sclerosis progresses faster in people who continue to smoke compared to smokers who quit after their diagnosis

MS Disease Progression May Be Delayed by Smoking Cessation

0
Each additional year of smoking accelerates time to secondary progressive disease by 5 percent
More Americans are getting health insurance as a result of the Affordable Care Act

Management, Treatment of Chronic Disease Up With ACA

0
Higher numbers of insured leading to more treatment of hypertension, high cholesterol, diabetes
Patients with delirium following major surgery are more likely to have worse outcomes

Post-Op Delirium Diminishes Recovery in Older Patients

0
Worse outcomes include increased hospital length of stay, disability, and mortality
Two newly approved medications to treat high cholesterol are extremely overpriced compared to the health benefits they give to patients

ICER: New Cholesterol Drugs Highly Overpriced

0
Newly FDA-approved Repatha and Praluent currently cost more than $14,000 per year
Having non-O blood group may be an independent risk factor for coronary artery disease and myocardial infarction

Non-O Blood Group Tied to Higher CAD, MI Risk

0
Findings based on meta-analysis involving 10 studies, nearly 175,000 people